Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Noro Psikiyatri Arsivi|January 7, 2020
A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE TrialGülşen Akman Demır, Recai Türkoğlu, Sabahattin Saıp, et al.
The Journal of Headache and Pain|March 16, 2006
Economic impact of primary headaches in Turkey: a university hospital based study: part IINecdet Karli, Mehmet Zarifoğlu, Mustafa Ertafş, et al.
CNS Drugs|June 24, 2021
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018Nahid Moradi, Sifat Sharmin, Charles Malpas, et al.
Neurology and Therapy|April 17, 2020
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative ReviewIsa Ahmed AlSharoqi, Mohamed Aljumah, Saeed Bohlega, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
External validation of a clinical prediction model in multiple sclerosisNahid Moradi, Sifat Sharmin, Charles B Malpas, et al.
Multiple Sclerosis and Related Disorders|February 6, 2023
Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activityTim Spelman, Dana Horakova, Serkan Ozakbas, et al.
Multiple Sclerosis and Related Disorders|November 29, 2017
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimodYara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Multiple Sclerosis and Related Disorders|May 31, 2020
'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'Serhan Sevim, Meltem Demirkıran, Murat Terzi, et al.
Multiple Sclerosis and Related Disorders|July 17, 2023
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical settingBengü Altunan, Aysun Ünal, Hüsnü Efendi, et al.
Journal of the Neurological Sciences|August 15, 2018
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapyIlya Kister, Tim Spelman, Francesco Patti, et al.
Pageof 16